HNRNPD
protein-codingheterogeneous nuclear ribonucleoprotein D, the group of Heterogeneous nuclear ribonucleoproteins|RNA binding motif containing
Gene summary
This gene belongs to the subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are nucleic acid binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has two repeats of quasi-RRM domains that bind to RNAs. It localizes to both the nucleus and the cytoplasm. This protein is implicated in the regulation of mRNA stability. Alternative splicing of this gene results in four transcript variants. [provided by RefSeq, Jul 2008]
- AUF1
- HNRPD
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~22.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
*HNRNPD* encodes a nuclear ribonucleoprotein implicated in mRNA processing mechanisms. *HNRNPD* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2021 (Gillentine et al., PMID: 33874999). Reported phenotypes include developmental delay, intellectual disability, speech and language delay, autism spectrum disorder, brain imaging abnormalities, growth delay, hypotonia, seizures, dystonia, dysmorphic facial features, and hand and feet abnormalities. Additional case reports with detailed clinical information are needed to better understand the phenotype spectrum. Fourteen variants (frameshift, nonsense, splice, and single gene deletion) that have been reported in 17 probands in four publications (PMIDs: 24768552, 33057194, 33874999, 35982159) are included in this curation. Thirteen occurred *de novo* and four were of unknown inheritance. *HNRNPD* is significantly constrained for loss-of-function variants (pLI = 1, LOEUF = 0.22, gnomAD v4.1.0). The fact that the majority of the reported variants are nonsense, frameshift or splice variants is consistent with a loss-of-function mechanism, but no functional studies have been performed. This gene-disease relationship is also supported by biochemical function and protein interaction. *HNRNPD* belongs to the heterogeneous nuclear ribonucleoprotein (HNRNP) gene family; several genes in this family (*HNRNPC*, *HNRNPH1*, *HNRNPH2*, *HNRNPK*, *SYNCRIP* [also known as *HNRNPQ*], *HNRNPR*, and *HNRNPU*) have recently been implicated in neurodevelopmental disorders with overlapping clinical features, including developmental delay, intellectual disability, autism spectrum disorder, epilepsy, and congenital anomalies. In summary, there is definitive evidence supporting the relationship between *HNRNPD* and autosomal dominant complex neurodevelopmental disorder. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on October 17, 2025 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: G2P
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HNRNPD variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_031370.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 37 | 37 | ||||
| nonsense | 2 | 1 | 3 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | 4 | ||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 1 | 3 | 43 | 2 | 0 | 49 |
Highest pathogenic variant AF is 0.000001299437
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_112738.1 | 8 | MANE Select | |
| Ensembl | ENSP00000313199.7 | 8 | MANE Select | |
| RefSeq | NP_001003810.1 | 6 | Standard | |
| RefSeq | NP_002129.2 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- mRNA Processing
- AUF1 (hnRNP D0) binds and destabilizes mRNA
- Metabolism of RNA
- mRNA Splicing - Major Pathway
- Regulation of mRNA stability by proteins that bind AU-rich elements
Biological Process
- mRNA splicing, via spliceosome
- liver development
- regulation of transcription, DNA-templated
- RNA processing
- RNA catabolic process
Molecular Function
- AT DNA binding
- chromatin binding
- RNA binding
- mRNA binding
- protein binding
Cellular Component
- nucleus
- nucleoplasm
- cytosol
- synapse
- ribonucleoprotein complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000313899
- Coding exons
- 8
- Length
- 22006
- Individuals with no LoFs
- 125738
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125742
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.45 | 91 | 185 | 0.492 | 0.00000885 | 2316 |
| Missense (PolyPhen) | 16 | 69.378 | 0.23062 | 890 | ||
| Synonymous | 1.48 | 50 | 65.1 | 0.768 | 0.00000342 | 648 |
| Loss of Function | 4.03 | 1 | 20.9 | 0.0479 | 0.00000106 | 253 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000035 | 0.000026 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3'-UTR of many proto- oncogenes and cytokine mRNAs. Also binds to double- and single- stranded DNA sequences in a specific manner and functions a transcription factor. Each of the RNA-binding domains specifically can bind solely to a single-stranded non-monotonous 5'-UUAG-3' sequence and also weaker to the single-stranded 5'-TTAGGG-3' telomeric DNA repeat. Binds RNA oligonucleotides with 5'-UUAGGG-3' repeats more tightly than the telomeric single-stranded DNA 5'- TTAGGG-3' repeats. Binding of RRM1 to DNA inhibits the formation of DNA quadruplex structure which may play a role in telomere elongation. May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. May play a role in the regulation of the rhythmic expression of circadian clock core genes. Directly binds to the 3'UTR of CRY1 mRNA and induces CRY1 rhythmic translation. May also be involved in the regulation of PER2 translation. {ECO:0000269|PubMed:10080887, ECO:0000269|PubMed:11051545, ECO:0000269|PubMed:24423872}.;
Recessive Scores
- pRec
- 0.426
Intolerance Scores
- LoFtool
- 0.160
- RVIS EVS
- -0.01
- RVIS percentile EVS
- 52.85
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- K
- Indispensability pred.
- E
- Indispensability score
- 0.903
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Low | Low | Low |
| Primary Immunodeficiency | Medium | Low | Medium |
| Cancer | Low | Low | Low |